Adeloye, D. et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(21)00511-7 (2022).
Soriano, J. B. et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch. Bronconeumol. 57, 61–69 (2021).
Golpe, R., Dacal-Rivas, D., Blanco-Cid, N. & Castro-Añon, O. Need for epidemiological studies on chronic obstructive pulmonary disease in rural Spain. Arch. Bronconeumol. 57, 614–615 (2021).
Asher, M. I., García-Marcos, L., Pearce, N. E. & Strachan, D. P. Trends in worldwide asthma prevalence. Eur. Respir. J. 56, 2002094 (2020).
Plaza, V., Blanco, M., Gabriel, J. K., Molina, J. & Quirce, S. Highlights of the Spanish asthma guidelines (GEMA), version 5.0. Arch. Bronconeumol. 57, 11–12 (2021).
Weycker, D., Hansen, G. L. & Seifer, F. D. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron. Respir. Dis. 14, 377–84. (2017).
PubMed PubMed Central Article Google Scholar
Athanazio, R. Airway disease: similarities and differences between asthma, COPD and bronchiectasis. Clinics (Sao Paulo) 67, 1335–1343 (2012).
Martinez-García, M. A. et al. RIBRON: the Spanish Online Bronchiectasis Registry. Characterization of the first 1912 patients. Arch. Bronconeumol. 57, 28–35 (2021).
Lonni, S. et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann. Am. Thorac. Soc. 12, 1764–1770 (2015).
PubMed PubMed Central Article Google Scholar
Chen, C. L. et al. The roles of bacteria and viruses in bronchiectasis exacerbation: a Prospective study. Arch. Bronconeumol. 56, 621–29. (2020).
CAS PubMed PubMed Central Article Google Scholar
Aliberti, A. et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(21)00277-0 (2021).
Fuschillo, S., De Felice, A. & Balzano, G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur. Respir. J. 31, 396–406 (2008).
CAS PubMed Article Google Scholar
Hill, A. T. et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax 74, 1–69 (2019).
Martinez-Garcia, M. A. et al. Spanish guidelines on treatment of bronchiectasis in adults. Arch. Bronconeumol. 54, 88–98 (2018).
Polverino, E. et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur. Respir. J. 50, 1700629 (2017).
Radovanovic, D. et al. A comprehensive approach to lung function in bronchiectasis. Respir. Med. 145, 120–129 (2018).
Saleh, A. D. et al. The heterogeneity of systemic inflammation in bronchiectasis. Respir. Med. 127, 33–39 (2017).
Posadas, T. et al. C-Reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish Registry of Bronchiectasis (RIBRON). Arch. Bronconeumol. 57, 21–27 (2021).
Martinez-Garcia, M. A. Bronchiectasis and eosinophils. Arch. Bronconeumol. 57, 671–672 (2021).
Shoemark, A., Shteinberg, M. & De Soyza, A. Characterisation of eosinophilic bronchiectasis: a European Multicohort Study., et al. Am. J. Respir. Crit. Care Med. https://doi.org/10.1164/rccm.202108-1889OC (2022).
Martinez-Garcia, M. A. et al. Repeatability of circulating eosinophil measures and inhaled corticosteroids effect in bronchiectasis. a post hoc analysis of a Randomized Clinical Trial. Arch. Bronconeumol. 56, 681–683 (2020).
Chalmers, J. D. & Sethi, S. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults. npj Prim. Care Respir. Med. 27, 18 (2017).
PubMed PubMed Central Article Google Scholar
Shah, A. & Panjabi, C. Allergic aspergillosis of the respiratory tract. Eur. Respir. J. 23, 8–29 (2014).
Naidich, D. P., McCauley, D. I., Khouri, N. F., Stitik, F. P. & Siegelman, S. S. Computed tomography of bronchiectasis. J. Comput. Assist. Tomogr. 6, 437–444 (1982).
CAS PubMed Article Google Scholar
Polverino, E. et al. The overlap between bronchiectasis and chronic airways diseases: state of the art and future directions. Eur. Respir. J. https://doi.org/10.1183/13993003.00328-2018 (2018).
Chalmers, J. D. et al. The Bronchiectasis Severity Index. An International Derivation and Validation Study. Am. J. Respir. Crit. Care Med. 189, 576–585 (2014).
PubMed PubMed Central Article Google Scholar
Martinez-Garcia, M. A. et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur. Respir. J. 43, 1357–1367 (2014).
Martinez-Garcia, M. A. et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int. J. COPD 12, 275–284 (2017).
McDonnell, M. J. et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international cohort study Lancet. Respir. Med. 4, 969–979 (2016).
Ni, Y. et al. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 1465–1475 (2015).
CAS PubMed PubMed Central Article Google Scholar
Matsumoto, H. Bronchiectasis in severe asthma and asthmatic components in bronchiectasis. Respir. Investig. 60, 187–196 (2022).
Martinez-Garcia, M. A. et al. Bronchial infection and temporal evolution of bronchiectasis in patients with chronic obstructive pulmonary disease. Clin. Infect. Dis. 72, 403–410 (2021).
CAS PubMed Article Google Scholar
Gruffydd-Jones, K. et al. Primary care implications of the British Thoracic Society. npj Prim. Care Respir. Med. 29, 24 (2019).
PubMed PubMed Central Article Google Scholar
Araújo, D. et al. The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur. Respir. J. 51, 1701953 (2018).
de la Rosa Carrillo, D. et al. Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease. Arch. Bronconeumol. 56, 651–666 (2020).
Amati, F. et al. Site of care and multidisciplinary approach. Eur. Respir. Mon. https://doi.org/10.1183/2312508X.10017117 (2018).
Cosío, B. et al. Implementation of an integrated care model for frequent-exacerbator COPD patients: a Controlled Prospective Study. Arch. Bronconeumol. 57, 577–583 (2021).
García, C. R., Barcala, F.-J. G. & Facal, D. Difficulties with Inhaled therapy: a complex simple technique. Arch. Bronconeumol. 56, 416–417 (2020).
Murray, M. P., Pentland, J. L., Turnbull, K., MacQuarrie, S. & Hill, A. T. Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur. Respir. J. 34, 361–364 (2009).
CAS PubMed Article Google Scholar
Vogelmeier, C. et al. The Global Strategy for Diagnosis, management and prevention of COPD (updated 2022). www.goldcopd.org.
Reddel, H. K. et al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur. Respir. J. 59, 2102730 (2022).
CAS PubMed PubMed Central Article Google Scholar
Facal, D., López-Lois, B. & Gonzalez-Barcala, F.-J. A current overview of the psychological aspects of asthma in adults. Arch. Bronconeumol. 56, 475–476 (2020)
Colomo, N. et al. Validity of self-rating screening scales for the diagnosis of depression and anxiety in adult patients with bronchiectasis. Arch. Bronconeumol. 57, 179–185 (2021).
Fernández-Villar, A., Fernández-García, S. & Represas-Represas, C. Is the social component of chronic obstructive pulmonary disease a treatable trait? Arch. Bronconeumol. 56, 199–200 (2020).
Laska, I., Crichton, M. L., Shoemark, A. & Chalmers, J. D. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis. Lancet Respir. Med. 7, 855–886 (2019).
CAS PubMed Article Google Scholar
Prados, C., Maiz, L., Zamarron, E. & Alvarez-Sala, R. Are inhalation devices important in antibiotic treatment? Arch. Bronconeumol. 56, 771–772 (2020).
Martinez-Garcia, M. A., Aksamit, T. R. & Aliberti, S. Bronchiectasis as a long-term consequence of SARS-COVID-19 pneumonia: future studies are needed. Arch. Bronconeumol. 57, 739–740 (2021).
PubMed PubMed Central Google Scholar
Halpin, D. M. G., Vogelmeier, C. F. & Agusti, A. COPD. and COVID-19. Arch. Bronconeumol. 57, 162–164 (2021).
留言 (0)